Document is current
Any future updates will be listed below
-
Authors
Rios, Shantel
Bhattachan, Bibek
Wirblich, Christoph
Chandwani, Anisha
Vavilikolanu, Kruthi
Myers, Jacob F.
Kitsou, Chrysoula
Pal, Utpal
Schnell, Matthias J.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (5R01AI154542)
National Institute of Allergy and Infectious Diseases (5R01AI154542)
NCI (P30CA056036-25)
2. Jefferson Center for Vaccines and Pandemic Preparedness (Internal Funds)
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 9 October 2025
First Online: 13 November 2025
Competing interests
: M.J.S. and S.R. have a pending patent application for an OspA-based vaccine based on RABV particles.
